Inhibition of pancreatic lipase

The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.

Saved in:
Bibliographic Details
Main Authors Richardson, Johnathan Craig, Dettmar, Peter William, Brownlee, Iain Andrew, Pearson, Jeffrey Peter, Wilcox, Matthew David
Format Patent
LanguageEnglish
Published 22.09.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.
Bibliography:Application Number: AU20100322840